Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Renalytix Plc (RENX) Share Price

Price 6.25p on 23-01-2026 at 19:35:11
Change 0.00p 0%
Buy 6.50p
Sell 6.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 1,532.00 at 6.24p
Day's Volume: 447,648
Last Close: 6.25p
Open: 6.25p
ISIN: GB00BYWL4Y04
Day's Range 6.25p - 6.25p
52wk Range: 5.75p - 11.50p
Market Capitalisation: £27.31m
VWAP: 6.079762p
Shares in Issue: 437.02m

Sector: Health Care and Related Services

Listed In: FTSE AIM All-Share,

Renalytix Plc (RENX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,532 6.24p Ordinary
 16:10:26 - 23-Jan-26
Sell* 18,128 6.15p Ordinary
 15:19:19 - 23-Jan-26
Sell* 48,383 6.045p Ordinary
 15:06:10 - 23-Jan-26
Sell* 25,000 6.045p Ordinary
 13:36:26 - 23-Jan-26
Sell* 200 6.025p Ordinary
 12:53:39 - 23-Jan-26
Buy* 15 6.50p SI Trade
 12:50:58 - 23-Jan-26
Buy* 215 6.50p SI Trade
 12:50:58 - 23-Jan-26
Buy* 163 6.50p SI Trade
 12:50:58 - 23-Jan-26
Buy* 153 6.50p SI Trade
 12:50:58 - 23-Jan-26
Buy* 15 6.50p SI Trade
 12:50:58 - 23-Jan-26
See more Renalytix Plc trades

Renalytix Plc (RENX) Share Price History

Time period:
to
Date Open High Low Close Volume
23rd Jan 2026 (Fri) 6.25 6.25 6.25 6.25 447,648
22nd Jan 2026 (Thu) 6.25 6.25 6.25 6.25 44,890
21st Jan 2026 (Wed) 6.25 6.25 6.25 6.25 332,109
20th Jan 2026 (Tue) 6.25 6.25 6.25 6.25 787,575
19th Jan 2026 (Mon) 6.25 6.25 6.25 6.25 621,295
16th Jan 2026 (Fri) 6.15 6.25 6.15 6.25 1,988,966
15th Jan 2026 (Thu) 6.25 6.25 6.15 6.15 197,387
14th Jan 2026 (Wed) 6.25 6.25 6.25 6.25 15,338
13th Jan 2026 (Tue) 6.25 6.25 6.25 6.25 298,710
12th Jan 2026 (Mon) 6.25 6.25 6.25 6.25 606,705
9th Jan 2026 (Fri) 6.25 6.25 6.25 6.25 74,399
8th Jan 2026 (Thu) 5.90 6.25 5.90 6.25 273,982
7th Jan 2026 (Wed) 5.90 5.90 5.90 5.90 153,990
6th Jan 2026 (Tue) 5.90 5.90 5.90 5.90 107,835
5th Jan 2026 (Mon) 5.90 5.90 5.90 5.90 410,060
2nd Jan 2026 (Fri) 5.90 5.90 5.90 5.90 193,360
1st Jan 2026 (Thu) 5.90 5.90 5.90 5.90 0
31st Dec 2025 (Wed) 5.90 5.90 5.90 5.90 620,320
30th Dec 2025 (Tue) 5.90 6.00 6.00 6.00 91,363
29th Dec 2025 (Mon) 5.90 5.80 5.80 5.80 561,166
26th Dec 2025 (Fri) 5.90 5.90 5.90 5.90 0
25th Dec 2025 (Thu) 5.90 5.90 5.90 5.90 0
24th Dec 2025 (Wed) 5.90 5.90 5.90 5.90 200,317
See more Renalytix Plc price history

Renalytix Plc (RENX) Regulatory News

Date Source Headline
21st Jan 2026 3:20 pm RNS Holding(s) in Company
15th Jan 2026 4:51 pm RNS Holding(s) in Company
12th Jan 2026 7:00 am RNS Three kidneyintelX.dkd Clinical Integrations
9th Jan 2026 2:43 pm RNS Holding(s) in Company
6th Jan 2026 4:28 pm RNS Holding(s) in Company
24th Dec 2025 12:56 pm RNS Holding(s) in Company
24th Dec 2025 12:56 pm RNS Holding(s) in Company
23rd Dec 2025 4:13 pm RNS Holding(s) in Company
23rd Dec 2025 4:13 pm RNS Holding(s) in Company
19th Dec 2025 12:18 pm RNS Holding(s) in Company
See more Renalytix Plc regulatory news

Renalytix Plc (RENX) Share News

TRADING UPDATES: Litigation Capital Management announces court win

13th Jan 2026 22:04

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

AIM WINNERS & LOSERS: MediaZest expects full-year earnings boost

9th Dec 2025 10:24

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Tuesday. Read More

IN BRIEF: Life Science REIT hires former Hipgnosis Songs Fund chair

3rd Dec 2025 12:11

Life Science REIT PLC - real estate investment trust for UK properties leased to tenants in the life science sector - Hires Robert Naylor to be senior independent director, starting on Wednesday. Naylor replaces Richard Howell as senior director, but Howell will remain a non-executive director. Naylor previously was chair of both Hipgnosis Songs Fund Ltd and peer Round Hill Music Royalty Fund Ltd. He currently is chair of Aquila European Renewables PLC and is a non-executive director of PRS REIT PLC, Niox Group PLC and Renalytix PLC. As an executive, Naylor is lead fund manager for Achilles Investment Co Ltd. He previously worked at JP Morgan Asset Management, Panmure Gordon and Cenkos Securities. Read More

IN BRIEF: Aquila European Renewables appoints Robert Naylor as chair

28th Nov 2025 16:10

Aquila European Renewables PLC - managed by Aquila Capital, invests in European renewable energy assets - Appoints Robert Naylor as non-executive chair, effective Friday this week. Confirms Non-Executive Chair Ian Nolan has retired from the board as of Thursday, having served in his role since prior to the IPO in 2019. Aquila highlights Naylor's 29 years of experience in capital markets, with him specialising in the investment trusts sector. Notes his current position as lead fund manager at Achilles Investment Company Ltd, and NED at PRS REIT PLC, Niox Group PLC and Renalytix PLC. Read More

TRADING UPDATES: Celsius raises funds; Built Cybernetics acquisition

12th Nov 2025 15:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

See more Renalytix Plc news
FTSE 100 Latest
Value10,143.44
Change-6.61

Login to your account

Forgot Password?

Not Registered